USA Today and Kaiser Health News
The state's Legislature has overwhelmingly approved a measure that would direct the state’s top health agency to partner with one or more drug companies by January to make or distribute a broad range of generic or biosimilar drugs.
Oxford University has signed an exclusive deal with AstraZeneca that gives the pharmaceutical giant sole rights with no guarantee of low prices.
A study published this month concluded that COVID outbreaks “could be a serious threat to the firefighting mission” and urged vigilant social distancing and screening measures in the camps.
Ever since he was a presidential candidate, President Donald Trump has been promising the American people a “terrific,” “phenomenal” and “fantastic” new health care plan to replace the Affordable Care Act.
Every day, the nation is reminded of COVID-19’s ongoing impact as new death counts are published. What is not well documented is the toll on family members.
During the next two months, vaccine makers hope to recruit 60,000 Americans, including in Oregon, to roll up their sleeves to test two vaccines.
With millions of lives on the line, researchers have been working at an unprecedented pace to develop a COVID-19 vaccine.
To feel comfortable, patients need to take stock of the precautions providers are taking. This is especially true for older adults, who are particularly vulnerable to COVID-19.
From Portland to Minneapolis to Miami, police officers have seriously injured civilian demonstrators with munitions designed to stop but not kill.